Position in NVS
as of Mar 31, 2026
· filed Apr 9, 2026
Position Value
$261,660
New position
Shares Held
1,713
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 7%
Shared 0%
None 93%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026DIVERSIFIED MANAGEMENT INC holds $8,173,871 across 7 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,013 | $2,414,452 | |
| 2 | JNJ |
Johnson & Johnson
|
7,731 | $1,963,442 | |
| 3 | ABBV |
AbbVie Inc.
|
5,888 | $1,481,656 | |
| 4 | MRK |
Merck & Co., Inc.
|
8,961 | $1,151,488 | |
| 5 | NVO |
Novo Nordisk A S
|
10,000 | $479,400 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,870 | $362,595 | |
| 7 | AMGN |
Amgen Inc
|
886 | $320,838 |
All Filings in NVS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $261,660 | 1,713 | Shares | Sole | 2026-04-09 | |
| No filing history on record for this holder in this stock. | ||||||